drugset / Trial / NCT02371096
Comparative Pharmacokinetic Trial of RGB-03 and MabThera
Summary
Pharmacokinetic properties, efficacy, safety and tolerability of RGB-03 and MabThera will be compared in patients suffering from Rheumatoid Arthritis.
Timeline
- Start
- —
- Primary completion
- 2016-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RGB-03 | Unknown | — | — |
| Comparator | Rituximab | Monoclonal antibody | — | — |